We have a custom synthesis offering by which we can rapidly provide peptides customised to your research needs. Whether an individual peptide bearing specialist modifications, or panels of overlapping peptides mapping across tumour associated antigens, we have the technical capabilities to serve your research needs.

We provide a range of specialist synthetic peptide/proteins that have applications in the cancer research field. Chemokines, histones and ubiquitylated peptides are available from stock in native or modified form. Particularly popular products are Alexa647® labelled chemokines and post-translationally modified H3 histones. All our products are produced synthetically, and so have total precision over non-natural modifications. Larger quantities, or non-stock items are available on a custom synthesis basis.

Our Neopeptides™ business was borne out of the need for the high throughput manufacture of neoantigen-derived peptides for use in individualised cancer vaccines. Rapid manufacture with full cGMP control has become a world-leading area of expertise, serving patients enrolled in clinical trials across the world.

We have a well-established cGMP manufacturing capability for the manufacture of peptides for clinical trials through to commercial products. We have significant experience in the manufacture of tumour associated antigens used as therapeutic vaccines for various tumour types.